Incyte Corporation
GB ˙ LSE ˙ US45337C1027
104,35 $ ↑3,62 (3,59%)
2026-06-05
DEL PRIS
SecurityGB:0J9P / Incyte Corporation
InstitutionQuadrant Capital Group Llc
Latest Disclosed Ownership4,425 shares
Latest Disclosed Value $ 416,481
Quadrant Capital Group Llc reports 2.60% decrease in ownership of 0J9P / Incyte Corporation

On May 13, 2026 - Quadrant Capital Group Llc filed a 13F-HR/A form disclosing ownership of 4,425 shares of Incyte Corporation (GB:0J9P) valued at $412,676 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 4,543 shares of Incyte Corporation. This represents a change in shares of -2.60% during the quarter. The current value of the position is $461,749 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 INCYTE COM 45337C102 4,425 -118 -2.60 416 -7.14 0.0125
2026-05-11 2026-03-31 13F INCYTE COM 45337C102 4,425 -118 49 0.0369
2026-02-12 2025-12-31 13F INCYTE COM 45337C102 4,543 26 0.58 449 16.97 0.0136
2025-11-13 2025-09-30 13F INCYTE COM 45337C102 4,517 64 1.44 383 26.40 0.0125
2025-08-13 2025-06-30 13F INCYTE COM 45337C102 4,453 572 14.74 303 29.49 0.0109
2025-05-13 2025-03-31 13F INCYTE COM 45337C102 3,881 3,382 677.76 235 588.24 0.0087
2025-02-13 2024-12-31 13F INCYTE COM 45337C102 499 0 0.00 34 6.25 0.0024
2024-11-12 2024-09-30 13F INCYTE COM 45337C102 499 -22 -4.22 33 3.23 0.0023
2024-08-12 2024-06-30 13F INCYTE COM 45337C102 521 -331 -38.85 32 -35.42 0.0023
2024-05-15 2024-03-31 13F INCYTE COM 45337C102 852 141 19.83 49 9.09 0.0038
2024-02-08 2023-12-31 13F INCYTE COM 45337C102 711 327 85.16 45 100.00 0.0038
2023-11-14 2023-09-30 13F INCYTE COM 45337C102 384 -338 -46.81 22 -50.00 0.0022
2023-08-10 2023-06-30 13F INCYTE COM 45337C102 722 -513 -41.54 45 -50.56 0.0045
2023-05-11 2023-03-31 13F INCYTE COM 45337C102 1,235 645 109.32 89 89.36 0.0093
2023-02-13 2022-12-31 13F INCYTE COM 45337C102 590 -287 -32.73 47 -18.97 0.0054
2022-11-10 2022-09-30 13F INCYTE COM 45337C102 877 209 31.29 58 13.73 0.0077
2022-08-09 2022-06-30 13F INCYTE COM 45337C102 668 82 13.99 51 10.87 0.0069
2022-05-06 2022-03-31 13F INCYTE COM 45337C102 586 124 26.84 46 35.29 0.0056
2022-02-01 2021-12-31 13F INCYTE COM 45337C102 462 4 0.87 34 6.25 0.0041
2021-11-12 2021-09-30 13F INCYTE COM 45337C102 458 -283 -38.19 32 -48.39 0.0045
2021-08-09 2021-06-30 13F INCYTE COM 45337C102 741 -78 -9.52 62 -7.46 0.0090
2021-05-12 2021-03-31 13F INCYTE COM 45337C102 819 237 40.72 67 31.37 0.0109
2021-02-16 2020-12-31 13F INCYTE COM 45337C102 582 -169 -22.50 51 -23.88 0.0095
2020-11-13 2020-09-30 13F INCYTE COM 45337C102 751 481 178.15 67 139.29 0.0146
2020-08-13 2020-06-30 13F INCYTE COM 45337C102 270 -426 -61.21 28 -46.15 0.0062
2020-05-15 2020-03-31 13F Incyte Com 45337C102 696 -262 -27.35 52 -32.47 0.0087
2020-03-19 2019-12-31 13F/A-1 Incyte Com 45337C102 958 254 36.08 77 57.14 0.0093
2020-02-03 2019-12-31 13F Incyte Com 45337C102 958 254 77 260.1930
2019-10-24 2019-09-30 13F Incyte COM 45337C102 704 -504 -41.72 49 -51.00 0.0075
2019-07-24 2019-06-30 13F Incyte COM 45337C102 1,208 245 25.44 100 25.00 0.0158
2019-04-29 2019-03-31 13F Incyte COM 45337C102 963 816 555.10 80 788.89 0.0141
2019-01-17 2018-12-31 13F INCYTE COM 45337C102 147 135 1,125.00 9 0.0024
2018-10-29 2018-09-30 13F INCYTE COM 45337C102 12 -97 -88.99 0 -100.00
2018-08-08 2018-06-30 13F INCYTE COM 45337C102 109 -533 -83.02 7 -84.09 0.0025
2018-05-10 2018-03-31 13F INCYTE COM 45337C102 642 326 103.16 44 91.30 0.0160
2018-01-31 2017-12-31 13F Incyte Pharmaceuticals COM 45337C102 316 -138 -30.40 23 -47.73 0.0092
2017-10-13 2017-09-30 13F Incyte Pharmaceuticals COM 45337C102 454 0 0.00 44 -12.00 0.0182
2017-08-14 2017-06-30 13F Incyte Pharmaceuticals COM 45337C102 454 93 25.76 50 19.05 0.0221
2017-04-10 2017-03-31 13F Incyte Pharmaceuticals COM 45337C102 361 45 14.24 42 68.00 0.0185
2017-01-11 2016-12-31 13F Incyte Pharmaceuticals COM 45337C102 316 4 1.28 25 8.70 0.0125
2016-10-25 2016-09-30 13F Incyte Pharmaceuticals COM 45337C102 312 -9 -2.80 23 15.00 0.0150
2016-07-28 2016-06-30 13F Incyte Pharmaceuticals COM 45337C102 321 182 130.94 20 150.00 0.0138
2016-04-27 2016-03-31 13F Incyte Pharmaceuticals COM 45337C102 139 45 47.87 8 0.00 0.0052
2016-01-28 2015-12-31 13F Incyte Pharmaceuticals COM 45337C102 94 -63 -40.13 8 -50.00 0.0055
2015-10-28 2015-09-30 13F Incyte Pharmaceuticals COM 45337C102 157 157 16 0.0110
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.